Works matching IS 07673981 AND DT 2025 AND VI 39 AND IP 1
Results: 15
Issue Information.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 1, p. 1, doi. 10.1111/fcp.13053
- Publication type:
- Article
Repurposing bosentan as an anticancer agent: EGFR/ERK/c‐Jun modulation inhibits NSCLC tumor growth.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 1, p. 1, doi. 10.1111/fcp.13052
- By:
- Publication type:
- Article
RETRACTION: Mineralocorticoid receptor antagonist‐mediated cognitive improvement in a mouse model of Alzheimer's type: possible involvement of BDNF‐H2S‐Nrf2 signaling.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 1, p. 1, doi. 10.1111/fcp.13051
- Publication type:
- Article
Long‐term evaluation of rheumatoid arthritis activity with erythrocyte methotrexate‐polyglutamate 3.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 1, p. 1, doi. 10.1111/fcp.13050
- By:
- Publication type:
- Article
Body mass index affects imatinib exposure: Real‐world evidence from TDM with adaptive dosing.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 1, p. 1, doi. 10.1111/fcp.13049
- By:
- Publication type:
- Article
Fluoxetine‐induced downregulation of circMap2k1 signaling cascade to improve neurological function after ischemic stroke.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 1, p. 1, doi. 10.1111/fcp.13048
- By:
- Publication type:
- Article
A novel naphthylchalcone ([E]‐4‐(3‐[naphthalen‐2‐yl]‐3‐oxoprop‐1‐en‐1‐yl) induces intrinsic and extrinsic apoptosis in human acute leukemia cell lines.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 1, p. 1, doi. 10.1111/fcp.13047
- By:
- Publication type:
- Article
Fundamental and Clinical Pharmacology of drug repositioning.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 1, p. 1, doi. 10.1111/fcp.13046
- By:
- Publication type:
- Article
Breastfeeding and contrast agents—A critical review and presentation of new aspects.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 1, p. 1, doi. 10.1111/fcp.13045
- By:
- Publication type:
- Article
Knockdown of RFC3 enhances the sensitivity of colon cancer cells to oxaliplatin by inducing ferroptosis.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 1, p. 1, doi. 10.1111/fcp.13044
- By:
- Publication type:
- Article
The synergy between alkylating agents and ERCC1–XPF inhibitors is p53 dependent.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 1, p. 1, doi. 10.1111/fcp.13043
- By:
- Publication type:
- Article
Capivasertib augments chemotherapy via Akt inhibition in preclinical small cell lung cancer models.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 1, p. 1, doi. 10.1111/fcp.13042
- By:
- Publication type:
- Article
New ways to repurpose salmeterol in an animal model of fibromyalgia.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 1, p. 1, doi. 10.1111/fcp.13041
- By:
- Publication type:
- Article
Induction of Ca<sup>2+</sup> signaling and cytotoxic responses of human lung fibroblasts upon an antihistamine drug oxatomide treatment and evaluating the protective effects of Ca<sup>2+</sup> chelating.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 1, p. 1, doi. 10.1111/fcp.13040
- By:
- Publication type:
- Article
In vitro evidence that the vasorelaxant effects of 2‐nitro‐1‐phenyl‐1‐propanol on rat coronary arteries involve cyclic nucleotide pathways.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 1, p. 1, doi. 10.1111/fcp.13038
- By:
- Publication type:
- Article